Neurocrine Biosciences Inc. (N1BI34)
Market Closed
7 Aug, 19:55
B3 B3 Primary R$
42. 92
0
0%
R$
89.45B Market Cap
63.27 P/E Ratio
- Div Yield
1 Volume
2.29 Eps
R$ 42.92
Previous Close Want to track N1BI34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurocrine Biosciences Inc. (N1BI34) Statistics
Valuation metrics
Market Cap 89.45B
Enterprise value 15.02B
Trailing P/E (ttm) 24.9
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 25.82
Price/Book (mrq) 4.92
Enterprise Value/Revenue 0.96
Enterprise Value/EBITDA 3.61
Overview
Shares outstanding 100.58M
Float 99.26M
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 313
Average volume (90 days) 125
Price summary
52-Week low 31.51
52-Week high 45.78
Beta 0.34
50-Day moving average 33.82
200-Day moving average 36.57
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.22%
Operating margin 0.23%
Operational effectiveness
Return on assets 0.12%
Return on equity 0.23%
Income Statement
Revenue (ttm) 15.58B
Revenue per share (ttm) 1.56
Quarterly revenue growth (yoy) 0.42%
Gross profit (ttm) 10.03B
EBITDA 780.2M
Net income to common (ttm) 3.36B
Diluted EPS (ttm) 1.6
Quarterly earnings growth (yoy) 24.05%
Balance Sheet
Total cash (mrq) 6.61B
Total cash per share (mrq) 13.09
Total debt (mrq) 2.33B
Total Debt/Equity (mrq) 13.6
Current ratio (mrq) 2.93%
Book value per share (mrq) 8.1
Cash Flow
Cash flow statement 4.34B
Levered free cash flow (LFCF) 2.97B
